Bokf Na cut its stake in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 14.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 43,661 shares of the semiconductor company's stock after selling 7,487 shares during the period. Bokf Na's holdings in Lam Research were worth $7,474,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of LRCX. PMV Capital Advisers LLC bought a new position in shares of Lam Research in the fourth quarter worth approximately $25,000. Stance Capital LLC bought a new position in shares of Lam Research in the third quarter worth approximately $26,000. Triumph Capital Management bought a new position in shares of Lam Research in the third quarter worth approximately $27,000. Strategic Wealth Investment Group LLC bought a new position in shares of Lam Research in the second quarter worth approximately $29,000. Finally, Measured Wealth Private Client Group LLC bought a new position in shares of Lam Research in the third quarter worth approximately $40,000. 84.61% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
LRCX has been the topic of several research analyst reports. B. Riley Financial restated a "buy" rating on shares of Lam Research in a research report on Monday, April 20th. Cantor Fitzgerald restated an "overweight" rating and issued a $320.00 price objective on shares of Lam Research in a research report on Thursday, April 23rd. New Street Research upped their price objective on shares of Lam Research from $235.00 to $280.00 and gave the stock a "neutral" rating in a research report on Monday, April 27th. Deutsche Bank Aktiengesellschaft upped their target price on Lam Research from $300.00 to $325.00 and gave the stock a "buy" rating in a research note on Thursday, April 23rd. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and issued a $290.00 target price on shares of Lam Research in a research note on Thursday, April 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $285.94.
Read Our Latest Research Report on Lam Research
Insider Buying and Selling
In other news, SVP Neil J. Fernandes sold 18,170 shares of the stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $255.14, for a total transaction of $4,635,893.80. Following the completion of the sale, the senior vice president owned 66,129 shares of the company's stock, valued at approximately $16,872,153.06. This represents a 21.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 35,000 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director directly owned 253,705 shares of the company's stock, valued at approximately $57,235,848. This trade represents a 12.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 155,066 shares of company stock worth $35,849,242. 0.31% of the stock is owned by company insiders.
Lam Research Stock Up 7.7%
Shares of LRCX opened at $297.17 on Thursday. The firm has a market cap of $371.63 billion, a P/E ratio of 56.07, a P/E/G ratio of 2.28 and a beta of 1.81. The stock has a 50 day simple moving average of $238.08 and a two-hundred day simple moving average of $203.95. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77. Lam Research Corporation has a 1 year low of $72.91 and a 1 year high of $297.87.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.11. The business had revenue of $5.84 billion during the quarter, compared to analyst estimates of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.Lam Research's revenue for the quarter was up 23.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. On average, analysts forecast that Lam Research Corporation will post 5.68 earnings per share for the current fiscal year.
More Lam Research News
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam reported a March-quarter beat and raised June-quarter guidance, signaling accelerating wafer‑fab demand and margin expansion — a primary driver of the rally. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
- Positive Sentiment: Wall Street momentum: multiple analysts have raised targets and issued buy/outperform ratings after the print — supporting upside and institutional demand. MarketBeat LRCX analyst coverage
- Positive Sentiment: Seaport Global initiated coverage with a buy, adding to the buy‑side chorus and increasing visibility among fund managers. Seaport Global initiates coverage of Lam Research (LRCX) with buy recommendation
- Positive Sentiment: Sector tailwinds: ETF/sector pieces point to heavy AI infrastructure capex benefiting semiconductor equipment suppliers like Lam. That narrative supports multiple quarters of elevated order flows. Semiconductor Leaders SOXX, SMH, and FTXL Are Crushing It on AI Infrastructure Demand
- Positive Sentiment: Industry capacity constraints (highlighted at KLA) suggest near-term tightness for key tools — reinforcing pricing power and order urgency for suppliers including Lam. KLA’s AI Capacity Constraints Highlight Earnings Power And Buyback Commitment
- Positive Sentiment: Technical/flow drivers: Lam cleared a buy point in IBD coverage after the beat, which can attract momentum and systematic buying. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
- Neutral Sentiment: Broad analyst consensus remains constructive (consensus "Moderate Buy"), which supports continued interest but already embeds much optimism. Lam Research Corporation NASDAQ: LRCX Receives Consensus Rating of "Moderate Buy" from Brokerages
- Negative Sentiment: Insider selling: an SVP sold shares under a Rule 10b5‑1 plan; while pre‑planned, the transaction can be viewed negatively by some traders. Insider Selling: Lam Research NASDAQ: LRCX SVP Sells 18,170 Shares of Stock
- Negative Sentiment: Valuation cautions: some commentators warn LRCX is approaching frothy levels after the run, which raises pullback risk if guidance or macro signals wobble. Lam Research Is Approaching Frothy Levels
Lam Research Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.